Target trial emulation of biologic and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis-associated interstitial lung disease.
Saved in:
| Title: | Target trial emulation of biologic and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis-associated interstitial lung disease. |
|---|---|
| Authors: | McDermott GC; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Solomon DH; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Sparks JA; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Desai RJ; Harvard Medical School, Boston, MA, USA; Division of Pharmacoepidemiology, Brigham and Women's Hospital, 1620 Tremont Street Suite 3030-R, Boston, MA 02120, USA; Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: rdesai@bwh.harvard.edu. |
| Source: | Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2026 Jun; Vol. 78, pp. 152973. Date of Electronic Publication: 2026 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: W.B. Saunders Country of Publication: United States NLM ID: 1306053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-866X (Electronic) Linking ISSN: 00490172 NLM ISO Abbreviation: Semin Arthritis Rheum Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
